We are live on
!
Find out more
AR
Advisory Research Portfolio holdings
AUM
$813M
1-Year Est. Return
36.71%
This Fund
S&P 500
This Quarter
Est. Return
+10.53%
1 Year Est. Return
+36.71%
3 Year Est. Return
+123.04%
5 Year Est. Return
+262.63%
10 Year Est. Return
+840.35%
AUM
$608M
AUM Growth
-$455M
(-43%)
Cap. Flow
-$486M
Cap. Flow
% of AUM
-79.89%
Top 10 Holdings %
Top 10 Hldgs %
19.27%
Holding
429
New
65
Increased
103
Reduced
150
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Maximus
MMS
|
+$9M |
| 2 |
ESGR
Enstar Group
ESGR
|
+$3.12M |
| 3 |
Symbotic
SYM
|
+$2.62M |
| 4 |
Miller Industries
MLR
|
+$2.62M |
| 5 |
PagerDuty
PD
|
+$2.45M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Diamondback Energy
FANG
|
+$67.9M |
| 2 |
Ovintiv
OVV
|
+$64.5M |
| 3 |
ERF
Enerplus Corporation
ERF
|
+$61.9M |
| 4 |
SM Energy
SM
|
+$48.8M |
| 5 |
DEN
Denbury Inc.
DEN
|
+$33.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.7% |
| 2 | Technology | 16.95% |
| 3 | Industrials | 13.89% |
| 4 | Financials | 13.4% |
| 5 | Healthcare | 12.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Boyd Gaming
BYD
$6.64B
| $360K | 0.06% |
5,612
-130
| -2% | -$8.05K |
|
277
Nu Skin
NUS
$250M
| $356K | 0.06% |
9,065
-202
| -2% | -$8.4K |
|
278
Prothena Corp
PRTA
$455M
| $347K | 0.06% |
7,151
+31
| +0.4% | +$1.64K |
|
279
Kiniksa Pharmaceuticals
KNSA
$4.89B
| $343K | 0.06% |
31,874
| – | – |
|
280
Rio Tinto
RIO
$150B
| $331K | 0.05% |
4,819
+1,228
| +34% | +$89.1K |
|
281
Shopify
SHOP
$165B
| $324K | 0.05% |
+6,768
| New | +$298K |
|
282
United Airlines
UAL
$39.1B
| $324K | 0.05% |
7,316
+85
| +1% | +$4.07K |
|
283
SoFi Technologies
SOFI
$21.7B
| $315K | 0.05% |
+51,853
| New | +$314K |
|
284
Holley
HLLY
$319M
| $313K | 0.05% |
114,240
-195,760
| -63% | -$500K |
|
285
Barclays
BCS
$96.3B
| $312K | 0.05% |
43,384
+11,123
| +34% | +$91.9K |
|
286
Ironwood Pharmaceuticals
IRWD
$644M
| $311K | 0.05% |
29,600
-693
| -2% | -$7.76K |
|
287
Patrick Industries
PATK
$2.81B
| $310K | 0.05% |
6,752
-231
| -3% | -$10.7K |
|
288
Trinity Capital
TRIN
$1.56B
| $309K | 0.05% |
24,241
-1,568
| -6% | -$20.5K |
|
289
Progress Software
PRGS
$1.59B
| $305K | 0.05% |
+5,304
| New | +$296K |
|
290
The Bancorp
TBBK
$2.81B
| $304K | 0.05% |
+10,899
| New | +$346K |
|
291
Unilever
UL
$132B
| $300K | 0.05% |
5,138
+1,225
| +31% | +$69.6K |
|
292
GSK
GSK
$104B
| $299K | 0.05% |
+8,397
| New | +$294K |
|
293
Legend Biotech
LEGN
$3.73B
| $291K | 0.05% |
6,041
+70
| +1% | +$3.42K |
|
294
Mayville Engineering Co
MEC
$751M
| $287K | 0.05% |
+19,206
| New | +$280K |
|
295
Hyster-Yale Materials Handling
HY
$596M
| $285K | 0.05% |
+5,721
| New | +$210K |
|
296
Consensus Cloud Solutions
CCSI
$669M
| $281K | 0.05% |
8,239
-171
| -2% | -$8.23K |
|
297
Verizon
VZ
$198B
| $281K | 0.05% |
7,220
| – | – |
|
|
BPAC
298
DELISTED
Bullpen Parlay Acquisition Company Class A Ordinary Share
BPAC
| $279K | 0.05% |
26,740
-2,820
| -10% | -$29.2K |
|
|
OPRA
299
Opera Ltd
OPRA
$1.69B
| $275K | 0.05% |
+27,089
| New | +$210K |
|
300
Genius Sports
GENI
$1.94B
| $273K | 0.04% |
54,868
-4,327
| -7% | -$20.3K |
|
Similar funds
VFG
SLG
KCP
UAG
PS
RPAM
BBI
SSG
Advisory Research's Q1 2023 Portfolio in Review
As of Q1 2023, Advisory Research held 429 positions worth $608M, down 43% from $1.06B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Advisory Research withdrew a net $486M in Q1 2023, closing 81 positions and reducing 150 holdings. Its most notable exit was Ovintiv, an estimated $64.5M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 8.6% a quarter earlier, followed by Technology and Industrials.
Against the trend, Advisory Research opened a new position in Maximus worth $9.19M.
- Advisory Research's largest Q1 2023 buy was Maximus: 116,828 shares worth $9.19M.
- Advisory Research added most to Enstar Group in Q1 2023, an estimated $3.12M increase.
- Advisory Research's biggest Q1 2023 reduction was Diamondback Energy, cutting an estimated $67.9M.
- Advisory Research fully exited Ovintiv in Q1 2023, selling an estimated $64.5M.
- Advisory Research's ten largest holdings make up 19% of its $608M portfolio in Q1 2023.
- Advisory Research opened 65 new positions and closed 81 in Q1 2023.
- Advisory Research's portfolio value fell 43% quarter-over-quarter to $608M.
Based on Advisory Research's 13F filing for Q1 2023, filed 12 May 2023.